Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Blair, Egerdie"'
Autor:
Barrett, Cowan, Eric, Klein, Ken, Jansz, Karl, Westenfelder, Timothy, Bradford, Chad, Peterson, Douglas, Scherr, Lawrence I, Karsh, Blair, Egerdie, Alfred, Witjes, Andrew, Trainer, Richard, Harris, Bernard, Goldfarb, Stanley, Flax, Robert, Kroeger, Buffi, Boyd, Joseph, Liao, Sanjay, Patel, Julia, Bridge, Victor, Reuter, Neil, Quigley, Sarah, Brown, Suling, Zhao, Malini, Satya, Michael, Bates, Iris M, Simon, Scott, Campbell, Yair, Lotan
Publikováno v:
BJU international. 128(6)
To evaluate the performance of the Xpert Bladder Cancer Monitor (Xpert; Cepheid, Sunnyvale, CA, USA) test as a predictor of tumour recurrence in patients with non-muscle-invasive bladder cancer (NMIBC).Patients (n = 429) undergoing surveillance for N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::41cde6774ae47aedc691e7fcd8f3b143
https://pubmed.ncbi.nlm.nih.gov/33793062
https://pubmed.ncbi.nlm.nih.gov/33793062
Autor:
Brenda Jenkins, Emmanuel Chartier-Kastler, Benjamin M. Brucker, Meryl Mandle, Alfred Kohan, Veronique Keppenne, Mark Tullman, Pierre Denys, Blair Egerdie, Jean Paul Nicandro
Publikováno v:
Neurology
ObjectiveTo evaluate the efficacy and safety of onabotulinumtoxinA 100 U in noncatheterizing patients with multiple sclerosis (MS) with urinary incontinence (UI) due to neurogenic detrusor overactivity (NDO).MethodsIn this randomized, double-blind ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73641d2fdd797350306fe28795a3dfd5
https://doi.org/10.1212/wnl.0000000000005991
https://doi.org/10.1212/wnl.0000000000005991
Autor:
J. Curtis Nickel, Blair Egerdie, Stephen Shrewsbury, Robert Evans, Lloyd F Mackenzie, Edward Davis
Publikováno v:
Journal of Urology. 196:747-754
In this 6-week, randomized, double-blind, placebo controlled, multicenter trial we assessed the effect of the novel SHIP1 (SH2-containing inositol-5'-phosphatase 1) activator AQX-1125 on bladder pain and urinary symptoms in patients with interstitial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46ae24aa9c56ed59e084a9983805e13
https://doi.org/10.1016/j.juro.2016.03.003
https://doi.org/10.1016/j.juro.2016.03.003
Autor:
Maxwell V. Meng, G. Kenneth Jansz, Joseph C. Liao, Joseph Zadra, Wade J. Sexton, Russell Higuchi, Leena McCann, R. Blair Egerdie, Malini Satya, Jun Zhang, Shoichiro Ohta, Kathleen E. Mach, Julia A. Bridge, Michael Woods, Andrew M. Hiar, Ellen Wallace, Mandy L. Y. Sin, Huilin Wei, Douglas S. Scherr, Bernard Goldfarb, Yair Lotan, Edith Wong, Alon Z. Weizer
Publikováno v:
The Journal of urology. 199(3)
Despite suboptimal sensitivity urine cytology is often performed as an adjunct to cystoscopy for bladder cancer diagnosis. We aimed to develop a noninvasive, fast molecular diagnostic test for bladder cancer detection with better sensitivity than uri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8082faab6b3385dc18a21a9a06021203
https://pubmed.ncbi.nlm.nih.gov/29061538
https://pubmed.ncbi.nlm.nih.gov/29061538
Autor:
Gavin Marx, Alison Stopeck, Ada Braun, Charles S. Cleeland, Roger von Moos, Felipe G. Palazzo, Blair Egerdie, Jean-Jacques Body, Donald L. Patrick, Karen Chung, Lesley Fallowfield, Yi Qian, Janet E. Brown, Danail Damyanov
Publikováno v:
Supportive Care in Cancer. 21:3497-3507
This analysis evaluated patient-reported outcomes and analgesic use in patients with bone metastases from solid tumours across three comparative studies of denosumab and zoledronic acid.Pooled data were analysed from three identically designed double
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae0a512a61e21276005f05c28ed3147
https://doi.org/10.1007/s00520-013-1932-2
https://doi.org/10.1007/s00520-013-1932-2
Publikováno v:
Journal of Endourology. 27:880-885
Current methods of suprapubic cystostomy (SPC) catheter insertion may be difficult for patients in poor health and can result in significant morbidity and mortality. These include a highly invasive open procedure, as well as the use of the percutaneo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022451644d95ea0f3587e32fe874d57e
https://doi.org/10.1089/end.2013.0053
https://doi.org/10.1089/end.2013.0053
Autor:
Jihao Zhou, Kyu-Sung Lee, Emmanuel Chartier-Kastler, Denise Bugarin, Joachim Grosse, Anand Patel, Blair Egerdie, Michael Marberger, Cornelia Haag-Molkenteller
Publikováno v:
European Urology. 63:496-503
Botulinum toxin treatment has been investigated as a minimally invasive alternative to oral medications in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (LUTS/BPH).To explore the efficacy of onabotulinumtoxin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2111c3f832b717a8b9d3eeff721f83ce
https://doi.org/10.1016/j.eururo.2012.10.005
https://doi.org/10.1016/j.eururo.2012.10.005
Publikováno v:
Journal of Urology. 195
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b14b9225467f91061af2c26a68db69ab
https://doi.org/10.1016/j.juro.2016.02.1626
https://doi.org/10.1016/j.juro.2016.02.1626
Autor:
Carsten Goessl, Matthew R. Smith, Benjamin Z. Leder, Fred Saad, Chunlei Ke, Blair Egerdie, Teuvo L.J. Tammela, Paul Sieber
Publikováno v:
Journal of Clinical Oncology. 30:3271-3276
Purpose To characterize changes in lean body mass (LBM) in men with prostate cancer receiving androgen-deprivation therapy (ADT). Patients and Methods We prospectively evaluated LBM in a prespecified substudy of a randomized controlled trial of denos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96686608d29b651047b045beb3f3db22
https://doi.org/10.1200/jco.2011.38.8850
https://doi.org/10.1200/jco.2011.38.8850
Autor:
Libby Black, Neil E. Fleshner, M. Scott Lucia, Roger S. Rittmaster, Gregg Eure, Blair Egerdie, Lorne Aaron, Indrani Nandy
Publikováno v:
The Lancet. 379:1103-1111
Summary Background We aimed to investigate the safety and efficacy of dutasteride, a 5α-reductase inhibitor, on prostate cancer progression in men with low-risk disease who chose to be followed up with active surveillance. Methods In our 3 year, ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c517ab1a8c9f8e4dad92c0f66abc2190
https://doi.org/10.1016/s0140-6736(11)61619-x
https://doi.org/10.1016/s0140-6736(11)61619-x